Literature DB >> 21914770

Immediate-early transcriptional response to angiotensin II in human adrenocortical cells.

Gerald Thiel1, Oliver G Rössler.   

Abstract

Angiotensin II binds to the angiotensin II receptors type 1 (AT1 receptors) in adrenocortical cells and triggers an intracellular signaling cascade leading to changes in the gene expression pattern. Here, we show that stimulation with angiotensin II induces the expression of biologically active early growth response (Egr)-1, a zinc finger transcription factor, in human H295R adrenocortical cells. Expression of a dominant-negative mutant of the ternary complex factor Elk-1, a key transcriptional regulator of serum response element-driven gene transcription, prevented Egr-1 expression in angiotensin II-stimulated H295R cells, indicating that Ets-like protein-1 (Elk-1) or related ternary complex factors connect the intracellular signaling cascade elicited by activation of AT1 receptors with transcription of the Egr-1 gene. These data were corroborated by the fact that angiotensin II stimulation increased the transcription activation potential of Elk-1. In addition, activator protein-1 transcriptional activity was significantly elevated in angiotensin II-treated H295R cells. Expression of c-Jun and c-Fos was increased as well as the transcription activation potential of c-Fos. Expression of a dominant-negative mutant of Elk-1 reduced c-Fos expression in angiotensin II-stimulated adrenocortical cells, suggesting that the serum response element within the c-Fos promoter functions as an angiotensin II-response element. Expression of a dominant-negative mutant of c-Jun reduced activator protein-1 activity in angiotensin II-stimulated adrenocortical cells and reduced the up-regulation of c-Jun after angiotensin II stimulation. Thus, c-Jun regulates its own expression in adrenocortical cells. Together, the data show that angiotensin II stimulation activates the transcription factors Egr-1, Elk-1, c-Jun, and c-Fos in adrenocortical cells, leading to stimulus-dependent changes in the gene expression pattern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914770     DOI: 10.1210/en.2011-1243

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Activation of gene transcription via CIM0216, a synthetic ligand of transient receptor potential melastatin-3 (TRPM3) channels.

Authors:  Sandra Rubil; Gerald Thiel
Journal:  Channels (Austin)       Date:  2016-06-29       Impact factor: 2.581

2.  Evidence that LDL receptor-related protein 1 acts as an early injury detection receptor and activates c-Jun in Schwann cells.

Authors:  Andreas Flütsch; Kenneth Henry; Elisabetta Mantuano; Michael S Lam; Masataka Shibayama; Kazuhisa Takahashi; Steven L Gonias; Wendy M Campana
Journal:  Neuroreport       Date:  2016-12-14       Impact factor: 1.837

3.  CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression.

Authors:  Sandra Rubil; Oliver G Rössler; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

4.  Combining fibroblast isolation with lentiviral gene transfer to validate transgene expression in mice following pronucleus injection.

Authors:  Oliver G Rössler; Andrea Lesch; Gerald Thiel
Journal:  Transgenic Res       Date:  2016-08-09       Impact factor: 2.788

5.  Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.

Authors:  Andrea Lesch; Sandra Rubil; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.

Authors:  Hátylas Azevedo; André Fujita; Silvia Yumi Bando; Priscila Iamashita; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 7.  The Hippo Pathway in Prostate Cancer.

Authors:  Omar Salem; Carsten G Hansen
Journal:  Cells       Date:  2019-04-23       Impact factor: 6.600

8.  TRPM3-Induced Gene Transcription Is under Epigenetic Control.

Authors:  Gerald Thiel; Oliver G Rössler
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.